electroCore (ECOR) Revenue Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | 51.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.07% |
| Dec 31, 2025 | 53.41% |
| Sep 30, 2025 | 63.83% |
| Jun 30, 2025 | 50.69% |
| Mar 31, 2025 | 52.38% |
| Dec 31, 2024 | 67.81% |
| Sep 30, 2024 | 63.96% |
| Jun 30, 2024 | 69.13% |
| Mar 31, 2024 | 65.35% |
| Dec 31, 2023 | 77.50% |
| Sep 30, 2023 | 60.97% |
| Jun 30, 2023 | 67.70% |
| Mar 31, 2023 | 55.89% |
| Dec 31, 2022 | 55.95% |
| Sep 30, 2022 | 42.49% |
| Jun 30, 2022 | 51.30% |
| Mar 31, 2022 | 66.75% |
| Dec 31, 2021 | 59.42% |
| Sep 30, 2021 | 114.36% |
| Jun 30, 2021 | 47.78% |
| Mar 31, 2021 | 145.69% |
| Dec 31, 2020 | 58.30% |
| Sep 30, 2020 | 56.31% |
| Jun 30, 2020 | 62.03% |